Eli Lilly and Company-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2013

  1. Randomized, phase II, placebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer

    Journal of Clinical Oncology, Vol. 31, Núm. 25, pp. 3127-3132

2007

  1. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

    Lancet Oncology, Vol. 8, Núm. 3, pp. 219-225

2003

  1. Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

    Annals of Oncology, Vol. 14, Núm. 8, pp. 1246-1252